Avenacy is a series b startup. 1 investor tracked. Status: possibledead.
Avenacy is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Avenacy is a U.S.-based specialty pharmaceutical company focused on supplying critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.